These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 39149873

  • 1. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
    Zhang A, Peng S, Sun S, Ye S, Zhao Y, Wu Q.
    Cancer Med; 2024 Aug; 13(16):e70100. PubMed ID: 39149873
    [Abstract] [Full Text] [Related]

  • 2. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L, Jiang Z, Wang J, Yang N, Qi Q, Zhou W, Feng Z, Li W, Zhang Q, Huang B, Chen A, Zhang D, Zhao P, Li X.
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [Abstract] [Full Text] [Related]

  • 3. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW, Ni Q, Fan YN, Ma ZX, Li YB.
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [Abstract] [Full Text] [Related]

  • 4. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J, Zhang XY, Sun DK, Tian LQ, Xu P.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y, He Y, Lv S, Hou X, Li L, Song J.
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [Abstract] [Full Text] [Related]

  • 6. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H, Ji D, Huang Z, Li J.
    Arch Biochem Biophys; 2020 Nov 30; 695():108628. PubMed ID: 33049294
    [Abstract] [Full Text] [Related]

  • 7. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y, Xie P.
    J Biochem Mol Toxicol; 2019 Nov 30; 33(11):e22392. PubMed ID: 31503386
    [Abstract] [Full Text] [Related]

  • 8. Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway.
    Zhao Z, Song Z, Wang Z, Zhang F, Ding Z, Zhao Z, Liu L, Fan T.
    Int J Immunopathol Pharmacol; 2024 Nov 30; 38():3946320241276336. PubMed ID: 39180753
    [Abstract] [Full Text] [Related]

  • 9. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway.
    Zheng Q, Diao S, Wang Q, Zhu C, Sun X, Yin B, Zhang X, Meng X, Wang B.
    J Cell Mol Med; 2019 Jan 30; 23(1):357-369. PubMed ID: 30353649
    [Abstract] [Full Text] [Related]

  • 10. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, Liu C, Xue N, Hong H, Xie J, Sun X, Yin B, Meng X, Wang B.
    J Exp Clin Cancer Res; 2022 May 17; 41(1):175. PubMed ID: 35581606
    [Abstract] [Full Text] [Related]

  • 11. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B, Morris AB, Spina R, Bar E, Schraner J, Vinkler R, Sohn JW, Welford SM.
    Cancer Lett; 2019 Oct 10; 462():33-42. PubMed ID: 31377205
    [Abstract] [Full Text] [Related]

  • 12. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
    Xue Z, Wang J, Wang Z, Liu J, Zhao J, Liu X, Zhang Y, Liu G, Zhao Z, Li W, Zhang Q, Li X, Huang B, Wang X.
    BMC Cancer; 2023 Jun 26; 23(1):589. PubMed ID: 37365560
    [Abstract] [Full Text] [Related]

  • 13. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
    Li Q, Liu X, Mao J, Liu S, Hou B, Li K, Fang D.
    Biochem Biophys Res Commun; 2023 Oct 08; 676():149-157. PubMed ID: 37517217
    [Abstract] [Full Text] [Related]

  • 14. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway.
    Yin X, Xia K, Peng S, Tan B, Huang Y, Wang M, He M.
    Dev Neurosci; 2024 Oct 08; 46(3):210-220. PubMed ID: 37757768
    [Abstract] [Full Text] [Related]

  • 15. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q, Guan Y, Li Z, Wang Y, Liu Y, Cui R, Wang Y.
    J Exp Clin Cancer Res; 2019 Aug 16; 38(1):358. PubMed ID: 31419987
    [Abstract] [Full Text] [Related]

  • 16. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J, Yang Y, Dong Y, Liu C.
    Int J Mol Med; 2022 Feb 16; 49(2):. PubMed ID: 34913078
    [Abstract] [Full Text] [Related]

  • 17. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y, Ma X, Wang Y, Li G.
    Biomed Pharmacother; 2017 Sep 16; 93():435-443. PubMed ID: 28666210
    [Abstract] [Full Text] [Related]

  • 18. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
    Mohajerani F, Tehrankhah ZM, Rahmani S, Afsordeh N, Shafiee S, Pourgholami MH, Soltani BM, Sadeghizadeh M.
    BMC Cancer; 2024 Jan 02; 24(1):19. PubMed ID: 38167030
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 02; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 20. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X, Wu S, Zhang J, Li M, Xu F, Wang A, Lei Y, Zhu G.
    Mol Med Rep; 2020 Sep 02; 22(3):1949-1957. PubMed ID: 32705169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.